source
- Lisata Therapeutics merges with Marea Therapeutics in reverse merger after failed Kuva dealLisata Therapeutics, a solid tumor biotech, announced a stock-for-stock merger with cardiovascular specialist Marea Therapeutics after a previous merger attempt with Kuva Labs collapsed. The trans…
- Rare inherited EGFR mutation raises lung cancer risk 62-fold in never-smokers, 25-fold in smokersResearchers examined genotyping data from 23andMe covering 3.37 million individuals and found the T790M germline mutation in about one out of every 15,850 people. The study reported that carriers…